Interestingly, targeting peripheral Ly6Chi monocytes with anti-Ly6C mAb reduces microglial infiltration and modifies the disease course in SOD1 mouse models indicating the monocytes and resident microglia in SOD1 mice influence ALS disease progression [167]. This evidence concerns the gene SOD1 and amyotrophic lateral sclerosis.